Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Adavosertib by AstraZeneca for Vaginal Cancer: Likelihood of Approval
Adavosertib is under clinical development by AstraZeneca and currently in Phase I for Vaginal Cancer. According to GlobalData, Phase I...
Adavosertib by AstraZeneca for Cervical Cancer: Likelihood of Approval
Adavosertib is under clinical development by AstraZeneca and currently in Phase I for Cervical Cancer. According to GlobalData, Phase I...
Adavosertib by AstraZeneca for Oral Cavity (Mouth) Cancer: Likelihood of Approval
Adavosertib is under clinical development by AstraZeneca and currently in Phase II for Oral Cavity (Mouth) Cancer. According to GlobalData,...
Adavosertib by AstraZeneca for Laryngeal Cancer: Likelihood of Approval
Adavosertib is under clinical development by AstraZeneca and currently in Phase II for Laryngeal Cancer. According to GlobalData, Phase II...
Adavosertib by AstraZeneca for Oropharyngeal Cancer: Likelihood of Approval
Adavosertib is under clinical development by AstraZeneca and currently in Phase II for Oropharyngeal Cancer. According to GlobalData, Phase II...